Agricultural Development of India: Policy and Problems C. H. Shah C. N. Vakil

Autor: Srinivasan, T. N.

Publikováno v: Economic Development and Cultural Change, 1983 Jan 01. 31(2), 430-431.

Externí odkaz: https://www.jstor.org/stable/1153494

345P The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

Autor: G. Liposits, H. Skuladottir, J. Ryg, S.B. Winther, S. Möller, E. Hofsli, C-H. Shah, L. Poulsen Oestergaard, A. Berglund, C. Qvortrup, P.J. Osterlund, J.S. Johansen, B. Glimelius, H. Sorbye, P. Pfeiffer

Publikováno v: Annals of Oncology. 33:S694

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4471e2e381741e76499acb64509693be
https://doi.org/10.1016/j.annonc.2022.07.483

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

Autor: Anders Ullén, Fredrik Jäderling, Per Grybäck, Mads Agerbæk, Helle Pappot, Jeffrey Yachnin, C.-H. Shah, H. Von Der Maase, Karin Holmsten

Publikováno v: Shah, C H, Pappot, H, Agerbæk, M, Holmsten, K, Jäderling, F, Yachnin, J, Grybäck, P, von der Maase, H & Ullén, A 2019, ' Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor) : Phase I Trial ', Oncologist, vol. 24, no. 6, pp. 745-e213 . https://doi.org/10.1634/theoncologist.2018-0795
The Oncologist

Lessons Learned First trial to report safety and activity of the microtubule inhibitor vinflunine plus the tyrosine kinase inhibitor sorafenib in post-platinum metastatic urothelial cancer (mUC) patients. A recommended phase II dose was identified fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3929a4c4a45f95a3a44374e26cc6eb
https://doi.org/10.1634/theoncologist.2018-0795

Effect of Stellate Ganglion Block on Dysphagia and Cognitive Impairment in Cerebral Small Vessel Disease: A Randomized Controlled Study.

Autor: Hongji Zeng¹, Weijia Zhao¹, Lixuan Fang², Huoying Pan³, Shaochun Huang⁴, Xi Zeng^5,6 zenghongjiclv@foxmail.com

Publikováno v: Journal of Speech, Language & Hearing Research. Oct2024, Vol. 67, p3660-3672. 13p.